Hostname: page-component-77f85d65b8-6bnxx Total loading time: 0 Render date: 2026-03-27T11:01:37.749Z Has data issue: false hasContentIssue false

A proposed crystal structure of fruquintinib Form I, C21H19N3O5

Published online by Cambridge University Press:  16 June 2025

James A. Kaduk*
Affiliation:
Department of Chemistry, Illinois Institute of Technology , 3101 South Dearborn Street, Chicago, IL 60616, USA Department of Physics, North Central College, 131 South Loomis Street, Naperville, IL 60540, USA
Anja Dosen
Affiliation:
International Centre for Diffraction Data (ICDD) , 12 Campus Boulevard, Newtown Square, PA 19073-3273, USA
Tom Blanton
Affiliation:
International Centre for Diffraction Data (ICDD) , 12 Campus Boulevard, Newtown Square, PA 19073-3273, USA
*
Corresponding author: James Kaduk; Email: kaduk@polycrystallography.com

Abstract

The crystal structure of fruquintinib Form I has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional theory techniques. Fruquintinib Form I crystallizes in space group C2 (#5) with a = 35.4167(22), b = 3.90500(12), c = 26.9370(11) Å, β = 108.0290(22)°, V = 3,542.52(26) Å3, and Z = 8 at 298 K. The crystal structure consists of double layers of each of the two independent molecules parallel to the ab-plane. These layers stack along the short b-axis. N–H···N hydrogen bonds link the layers. Most of the C–H···N and C–H···O hydrogen bonds are intramolecular. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File (PDF®).

Information

Type
New Diffraction Data
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of International Centre for Diffraction Data
Figure 0

Figure 1. The two-dimensional molecular structure of fruquintinib.

Figure 1

Figure 2. The Rietveld plot for fruquintinib Form I. The blue crosses represent the observed data points, and the green line is the calculated pattern. The cyan curve is the normalized error plot, and the red line is the background curve. The blue tick marks indicate the fruquintinib peak positions. The vertical scale has been multiplied by a factor of 10× for 2θ > 18.0̊.

Figure 2

Figure 3. Comparison of the synchrotron pattern of fruquintinib (black) to that reported for Form I by Sheng and Sheng (2019) (green). The literature pattern (measured using Cu Kα radiation) was digitized using UN-SCAN-IT (Silk Scientific, 2013) and converted to the synchrotron wavelength of 0.819563(2) Å using JADE Pro (MDI, 2024). Image generated using JADE Pro (MDI, 2024).

Figure 3

Figure 4. Comparison of the Rietveld-refined (red) and VASP-optimized (blue) structures of fruquintinib molecule 1. The root-mean-square Cartesian displacement is 0.557 Å. Image generated using Mercury (Macrae et al., 2020).

Figure 4

Figure 5. Comparison of the Rietveld-refined (red) and VASP-optimized (blue) structures of fruquintinib molecule 2. The root-mean-square Cartesian displacement is 0.342 Å. Image generated using Mercury (Macrae et al., 2020).

Figure 5

Figure 6. The asymmetric unit of fruquintinib Form I, with the atom numbering. The atoms are represented by 50% probability spheroids. Image generated using Mercury (Macrae et al., 2020).

Figure 6

Figure 7. Comparison of molecule 1 (green) and molecule 2 (orange) of fruquintinib Form I. Image generated using Mercury (Macrae et al., 2020).

Figure 7

TABLE I. Unusual (Mogul) bond distances and angles in the VASP-optimized structure of fruquintinib

Figure 8

Figure 8. Crystal structure of fruquintinib Form I, viewed down the b-axis. Molecule 1 is colored green, and molecule 2 is orange. Image generated using Mercury (Macrae et al., 2020). The cyan lines indicate hydrogen bonds within an asymmetric unit, and the red lines indicate hydrogen bonds between asymmetric units.

Figure 9

TABLE II. Hydrogen bonds (CRYSTAL23) in fruquintinib

Figure 10

Figure 9. The Hirshfeld surface of fruquintinib Form I. Intermolecular contacts longer than the sums of the van der Waals radii are colored blue, and contacts shorter than the sums of the radii are colored red. Contacts equal to the sums of radii are white. Image generated using CrystalExplorer (Spackman et al., 2021).

Figure 11

Figure 10. The Bravais–Friedel–Donnay–Harker morphology for fruquintinib Form I. Image generated using Mercury (Macrae et al., 2020).